A novel RNA-based blood test enables early, accurate, and affordable detection of Parkinson’s disease before symptoms appear.

A research team from the International Research Center for Medical Sciences (IRCMS) at Kumamoto University has identified a ...

Mitochondrial diseases, arising from mutations in mitochondrial DNA (mtDNA), are a diverse group of disorders that lead to ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

A team of researchers in Kumamoto University uncovered a previously unrecognized role of mitochondrial protein synthesis in ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company ...

RNA therapeutics market is expanding, driven by advancements in gene therapy, personalized medicine, and RNA-based drug delivery, along with rising research in mRNA vaccines, antisense ...

The Business Journal found 21 Massachusetts life sciences companies announced layoffs impacting at least 1,000 employees ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective at killing both gram-positive and gram-negative pathogenic bacteria, along ...

SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of ...

Mechanistic studies demonstrated that 10-F05 inhibits bacterial growth by inactivating FabH, while its interaction with MiaA disrupts substrate tRNA binding, reducing translation fidelity ...